Key statistics
On Friday, argenx SE (1AE:STU) closed at 650.40, -19.62% below its 52-week high of 809.20, set on Nov 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 651.60 |
|---|---|
| High | 668.00 |
| Low | 648.20 |
| Bid | 651.60 |
| Offer | 653.80 |
| Previous close | 681.80 |
| Average volume | 5.43 |
|---|---|
| Shares outstanding | 61.88m |
| Free float | 61.88m |
| P/E (TTM) | 39.73 |
| Market cap | 40.63bn EUR |
| EPS (TTM) | 16.52 EUR |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Announcements
- argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
- argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
- argenx to Present at TD Cowen 46th Annual Healthcare Conference
- argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
- argenx Announces FDA Acceptance of Supplemental Biologics License Application with Priority Review for VYVGART in AChR-Ab Seronegative gMG
- argenx Highlights 2026 Strategic Priorities
- argenx to Present at 44th Annual J.P. Morgan Healthcare Conference
- argenx Announces Leadership Transition Marking Next Evolution of Growth
- argenx Provides Update on UplighTED Studies of Efgartigimod SC in Thyroid Eye Disease
- argenx Announces Results of Extraordinary General Meeting of Shareholders
More ▼
